|
 |
Scott B. Cantor, Ph.D. Associate Professor of Health Services Research Associate Decision Scientist |
Contact Information
Health Services Research Department of Biostatistics The University of Texas M. D. Anderson Cancer Center 1515 Holcombe Blvd, Unit 447 Houston TX 77030-4009 Phone: (713) 745-5984 Fax: (713) 563-4243 E-mail: sbcantor@mdanderson.org
Degrees
Areas of Interest
- Theoretical issues of cost-effectiveness analysis and diagnostic testing
- Clinical issues of cancer prevention, particularly prostate cancer screening and diagnosis of cervical intraepithelial neoplasia
- Additional collaborative studies have focused on outcomes preferences in cancer screening and treatment and the economic evaluation of diagnostic and therapeutic interventions
Dr. Cantor is a clinical decision analyst. In addition to a faculty appointment at M. D. Anderson, he holds appointments as an Adjunct Associate Professor of Biostatistics at Rice University and The University of Texas School of Public Health, and as a Faculty Member at The University of Texas Graduate School of Biomedical Sciences.
Dr. Cantor was President (2003-2004) of the Society for Medical Decision Making, the professional society dedicated to promoting quantitative approaches to decision making to improve the health and clinical care of individuals and to assist in health policy formation. Previously, he served as Vice President (2000-2001) and Trustee (1997-1999) on the Board of Trustees. He also served as an Assistant Editor (1994-1997) for the Society's methodological journal Medical Decision Making and as Program Chair for the Society's 19th Annual Meeting. He is also a member of the Decision Analysis Society of INFORMS, the Society for Judgment and Decision Making, and the American Society of Clinical Oncology.
Publications 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999
2008 Back to top
Cantor SB, Volk RJ, Krahn MD, Cass AR, Gilani J, Weller SC, Spann SJ. Concordance of couples' prostate cancer screening recommendations from a decision analysis. The Patient 2008; 1:11-19.
Cárdenas-Turanzas M, Follen M, Nogueras-Gonzalez GM, Benedet JL, Beck JR, Cantor SB. The accuracy of the Papanicolaou smear in the screening and diagnostic settings. Journal of Lower Genital Tract Disease. In Press.
Caviness AC, Swint JM, Demmler GJ, Cantor SB. Cost-effectiveness analysis of herpes simplex virus testing and treatment strategies in febrile neonates. Archives of Pediatrics & Adolescent Medicine. In Press.
Jones JA, Qazilbash MH, Shih YCT, Cantor SB, Cooksley CD, Elting LS. In-hospital complications of autologous hematopoeitic stem cell transplantation for lymphoid malignancies: clinical and economic outcomes from the Nationwide Inpatient Sample. Cancer 2008; 112:1096-1105.
Cantor SB, Cárdenas-Turanzas M, Cox DD, Atkinson EN, Nogueras-Gonzalez GM, Beck JR, Follen M, Benedet JL. Accuracy of colposcopy in the diagnostic setting compared with the screening setting. Obstetrics and Gynecology 2008; 111:7-14.
2007 Back to top
Davies KR, Cox DD, Swartz RJ, Cantor SB, Follen M. Inverse decision theory with applications to screening and diagnosis of cervical intraepithelial neoplasia. Gynecologic Oncology 2007; 107:S187-S195.
Cardenas-Turanzas M, Freeberg JA, Benedet JL, Atkinson EN, Richards-Kortum R, MacAulay C, Follen M, Cantor SB. The clinical effectiveness of optical spectroscopy for the in vivo diagnosis of cervical intraepithelial neoplasia: where are we? Gynecologic Oncology 2007; 107:S138-S146.
Cong X, Cox DD, Cantor SB. Bayesian meta-analysis of Papanicolaou smear accuracy. Gynecologic Oncology 2007; 107:S133-S137.
Basen-Engquist K, Fouladi RT, Cantor SB, Shinn EH, Sui D, Sharman M, Follen M. Patient assessment of tests to detect cervical cancer. International Journal of Technology Assessment in Health Care 2007; 23(2):240-247.
Avritscher EB, Cooksley CD, Geraci JM, Bekele BN, Cantor SB, Rolston KV, Elting LS. Cost-effectiveness of influenza vaccination in working-age cancer patients. Cancer 2007; 109(11):2357-2364.
Cormier JN, Xing Y, Ding M, Cantor SB, Salter K, Lee JE, Mansfield PF, Gershenwald JE, Ross MI. Cost effectiveness of adjuvant interferon in node-positive melanoma. Journal of Clinical Oncology 2007; 25:2442-2448.
Elting LS, Shih YCT, Stiff PJ, Bensinger W, Cantor SB, Cooksley CD, Speilberger R, Emmanoulides C. Economic impact of palifermin on the cost of hospitalization for autologous hematopoietic stem-cell transplantation: Analysis of phase III trial results. Biology of Blood and Marrow Transplantation 2007; 13:806-813.
2006 Back to top
Cantor SB, Levy LB, Cardenas-Turanzas M, Basen-Engquist K, Le T, Beck JR, Follen M. Collecting direct non-health-care and time cost data: application to screening and diagnosis of cervical cancer. Medical Decision Making 2006; 26:265-272.
Guillaud M, Benedet JL, Cantor SB, Staerkel G, Follen M, MacAulay C. DNA ploidy compared to human papilloma virus testing (Hybrid Capture II) and conventional cervical cytology as a primary screening test for cervical high grade lesions and cancer in 1555 patients with biopsy confirmation. Cancer 2006; 107:309-318.
Jeruss JS, Hunt KK, Xing Y, Krishnamurthy S, Meric-Bernstam F, Cantor SB, Ross MI, Cormier JN. Is intraoperative touch imprint cytology of sentinel lymph nodes in patients with breast cancer cost effective? Cancer 2006; 107:2328-2336.
Lee JJ, Bekele BN, Zhou X, Cantor SB, Komaki R, Lee JS. Decision analysis of prophylactic cranial irradiation for patients with small cell lung cancer. Journal of Clinical Oncology 2006; 24:3597-3603.
Palos GR, Cantor SB, Aday L, Mendoza TR, Mobley G, Cleeland CS. An urban community's preferences for hypothetical outcomes of analgesic pain treatment. Journal of Pain and Symptom Management 2006; 32(5):470-477.
Palos GR, Mendoza TR, Mobley GM, Cantor SB, Cleeland CS. Asking the community about cutpoints used to describe mild, moderate, and severe pain. The Journal of Pain 2006; 7(1):49-56.
Shih YC, Wang XS, Cantor SB, Cleeland CS. The association between symptom burdens and utility in Chinese cancer patients. Quality of Life Research 2006; 15(8):1427-1438.
Smith TJ, Khatcheressian J, Lyman GH, Ozer H, Armitage JO, Balducci L, Bennett CL, Cantor SB, Crawford J, Cross SJ, Demitri G, Desch CE, Pizzo PA, Schiffer CA, Schwartzberg L, Somerfield M, Somlo G, Wade JC, Wade JL, Winn RJ, Wozniak AJ, Wolff AC. 2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline. Journal of Clinical Oncology 2006; 24:3187-3205.
Swartz RJ, Cox DD, Cantor SB, Davies K, Follen M. Inverse decision theory: characterizing losses for a decision rule with applications in cervical cancer screening. Journal of the American Statistical Association 2006; 101:1-8.
Tortolero-Luna G, Byrd T, Groff JY, Linares AC, Mullen PD, Cantor SB. Relationship between English language use and preferences for involvement in medical care among Hispanic women. Journal of Women's Health 2006; 15(6):774-785.
2005 Back to top
Cantor SB. 26th annual meeting of the Society for Medical Decision Making Presidential Address: Connections. Medical Decision Making 2005; 25:119-126.
Cantor SB, Atkinson EA, Cardenas-Turanzas MD, Benedet JL, Follen M, MacAulay C. Natural history of cervical intraepithelial neoplasia: a meta-analysis. Acta Cytologica 2005; 49:405-415.
Cantor SB, Byrd T, Groff JY, Reyes Y, Tortolero-Luna G, Mullen PD. The language translation process in survey research: a cost analysis. Hispanic Journal of Behavioral Sciences 2005; 27:364-370.
Cardenas-Turanzas MD, Follen M, Benedet JL, Cantor SB. See-and-treat strategy for the diagnosis and management of cervical squamous intraepithelial lesions. The Lancet Oncology 2005;6:43-50.
Follen M, Crain S, MacAulay C, Basen-Engquist K, Cantor SB, Cox D, Atkinson EN, MacKinnon N, Guillaud M, Richards-Kortum R. Optical technologies for cervical neoplasia: update of an NCI program project grant. Clinical Advances in Hematology and Oncology 2005; 3:41-53.
Shih YCT, Han S, Cantor SB. Impact of generic drug entry on cost-effectiveness analysis. Medical Decision Making 2005; 25:71-80.
2004 Back to top
Avritscher EBC, Cantor SB, Shih YCT, Escalante CP, Rivera E, Elting LS. Cost-minimization analysis of low-molecular-weight heparin (dalteparin) compared to unfractionated heparin for inpatient treatment of cancer patients with deep venous thrombosis. Supportive Care in Cancer 2004; 12:531-536.
Cantor SB. Clinical applications in the decision analysis literature. Decision Analysis 2004; 1:25-28.
Caviness AC, Cantor SB, Allen CH, Eard MA. A cost-effectiveness analysis of bacterial endocarditis prophylaxis for febrile children with cardiac lesions who undergo urinary catheterization in the emerency department. Pediatrics 2004; 113:1291-1296.
Cormier JN, Xing Y, Ross MI, Cantor SB. Interferon-alpha in high-risk melanoma patients. Expert Reviews in Pharmacoeconomics Outcomes Research 2004; 4:667-676.
Nath A, Rivoire K, Chang S, West L, Cantor SB, Basen-Engquist K, Adler-Storthz K, Cox DD, Atkinson EN, Staerkel G, MacAulay C, Richards-Kortum R, Follen M. A pilot study for a screening trial of cervical fluorescence spectroscopy. International Journal of Gynecological Cancer 2004; 14:1097-1107.
Palos GR, Mendoza TR, Cantor SB, Aday LA, Cleeland CS. Perceptions of analgesic use and side effects: what the public values in pain management. Journal of Pain and Symptom Management 2004; 28:460-473.
Porter GA, Cantor SB, Walsh GL, Rusch VW, Leung DH, DeJesus AY, Pollock RE, Brennan MF, Pisters PWT. Cost-effectiveness of pulmonary resection and systemic chemotherapy in the management of metastatic soft tissue sarcoma: a combined analysis from The University of Texas M. D. Anderson and Memorial Sloan-Kettering Cancer Centers. Journal of Thoracic and Cardiovascular Surgery 2004; 127:1366-1372.
Volk RJ, Cantor SB, Cass AR, Spann SJ, Weller SC, Krahn MD. Preferences of husbands and wives for outcomes of prostate cancer screening and treatment. Journal of General Internal Medicine 2004; 19:339-348.
2003 Back to top
Cantor SB, Elting LS, Hudson DV, Rubenstein EB. Pharmacoeconomic analysis of oprelvekin (recombinant human interleukin-11) for secondary prophylaxis of thrombocytopenia in solid tumor patients receiving chemotherapy. Cancer 2003; 97:3099-3106.
Cantor SB, Fahs MC, Mandelblatt JS, Myers ER, Sanders GD. Decision science and cervical cancer. Cancer 2003; 98:2003-2008.
Chau Q, Cantor SB, Caramel E, Hicks M, Kurtin D, Grover T, Elting LS. Cost-effectiveness of the bird's nest filter for preventing pulmonary embolism among patients with malignant brain tumors and deep venous thrombosis of the lower extremities. Supportive Care in Cancer 2003; 11(12):795-799.
Elting LS, Cantor SB, Martin CG, Hamblin L, Kurtin DJ, Rivera E, Vadhan-Raj S, Benjamin RS. Cost of chemotherapy-induced thrombocytopenia among patients with lymphoma or solid tumors. Cancer 2003; 97(6):1541-1550.
Elting LS, Cooksley C, Chambers M, Cantor SB, Manzullo E, Rubenstein EB. The burdens of cancer therapy. Clinical and economic outcomes of chemotherapy-induced mucositis. Cancer 2003; 98(7):1531-1539.
2002 Back to top
Cantor SB. Pharmacoeconomics of coxib therapy. Journal of Pain and Symptom Management 2002; 24:S28-S37.
Cantor SB, Volk RJ, Cass AR, Gilani J, Spann SJ. Psychological benefits of prostate cancer screening: the role of reassurance. Health Expectations 2002; 5:104-113.
Elting LS, Cantor SB. Outcomes and costs of febrile neutropenia: adventures in the science and art of treatment choices. Supportive Care in Cancer 2002; 10(3):189-196.
Elting LS, Martin CG, Kurtin DJ, Cantor SB, Rubenstein EB, Rodriguez S, Kanesan K, Vadhan-Raj S, Benjamin RS. The bleeding risk index: a clinical prediction rule to guide the prophylactic use of platelet transfusions in patients with lymphoma or solid tumors. Cancer 2002; 94:3252-3262.
Esnaola NF, Cantor SB, Johnson ML, Mirza AN, Miller AR, Curley SA, Crane CH, Cleeland CS, Janjan NA, Skibber JM. Pain and quality of life after treatment in patients with locally recurrent rectal cancer. Journal of Clinical Oncology 2002; 20:4361-4367.
Porter GA, Cantor SB, Ahmad SA, Lenert JT, Ballo MT, Hunt KK, Feig BW, Patel, Benjamin RS, Pollock RE, Pisters PW. Cost-effectiveness of staging computed tomography of the chest in patients with T2 soft tissue sarcomas. Cancer 2002; 94(1):197-204.
Shureiqi I, Cantor SB, Lippmann SM, Brenner DE, Chernew ME, Fendrick AM. Clinical and economic impact of multiple gated acquisition scan monitoring during anthracycline therapy. British Journal of Cancer 2002; 86(2):226-232.
2001 Back to top
Elting LS, Rubenstein EB, Kurtin D, Martin CG, Rodriguez S, Cantor SB, Laiho E, Kanesan K, Benjamin RS. Incidence, cost, and outcomes of bleeding and chemotherapy does modification among solid tumor patients with chemotherapy-induced thrombocytopenia. Journal of Clinical Oncology 2001; 19(4):1137-1146.
Esnaola NF, Cantor SB, Sherman SI, Lee JE, Evans DB. Optimal treatment strategy in patients with papillary thyroid cancer: a decision analysis. Surgery 2001; 130(6):921-930.
Fleming JB, Cantor SB, Varma DG, Holst D, Feig BW, Hunt KK, Patel SR, Benjamin RS, Pollock RE, Pisters PW. Utility of chest computed tomography for staging in patients with T1 extremity soft tissue sarcomas. Cancer 2001; 92(4):863.868.
2000 Back to top
Cantor SB, Kattan MW. Determining the area under the ROC curve for a binary diagnostic test. Medical Decision Making 2000; 20(4):468-470.
Elting LS, Rubenstein EB, Rolstson K, Cantor SB, Martin CG, Kurtin D, Rodriguez S, Lam T, Kanesan K, Bodey GP. Time to clinical response: an outcome of antibiotic therapy of febrile neutropenia with implications for quality and cost of care. Journal of Clinical Oncology 2000; 18(21):3699-3706.
Escalante CP, Martin CG, Elting LS, Price KJ, Manzullo EF, Weiser MA, Harle TS, Cantor SB, Rubenstein EB. Identifying risk factors for imminent death in cancer patients with acute dyspnea. Journal of Pain and Symptom Management 2000; 20(5):318-325.
Ganiats TG, Carson RT, Hamm RM, Cantor SB, Sumner W, Spann SJ, Hagen MD, Miller CM. Population-based time preferences for future health outcomes. Medical Decision Making 2000; 20(3):263-270.
Miller AR, Cantor SB, Peoples GE, Pearlstone DB, Skibber JM. Quality of life and cost-effectiveness analysis of therapy for locally recurrent rectal cancer. Dis Colon Rectum. 2000;43(12):1695-1703.
1999 Back to top
Cantor SB, Ganiats TG. Incremental cost-effectiveness analysis: the optimal strategy depends on the strategy set. Journal of Clinical Epidemiology 1999; 52(6):517-522.
Cantor SB, Sun CC, Tortolero-Luna G, Richards-Kortum R, Follen M. A comparison of C/B ratios from studies using receiver operating characteristic curve analysis. Journal of Clinical Epidemiology 1999; 52(9):885-892.
Elting LS, Martin CG, Cantor SB, Rubenstein EB. Influence of data display formats on physician investigators' decisions to stop clinical trials: prospective trial with repeated measures. BMJ 1999; 318(7197):1527-1531.
Kattan MW, Fearn PA, Cantor SB, Hu J, Cowen ME, Giesler RB, Miles BJ. Telephone interviews vs. workstation sessions for acquiring quality of life data. Proceedings of the AMIA Annual Symposium 1999; 23:296-300.
Mitchell MF, Cantor SB, Ramanujam N. Tortolero-Luna G, Richards-Kortum R. Fluorescence spectroscopy for diagnosis of squamous intraepithelial lesions of the cervix. Obstetetrics and Gynecology 1999; 93(3):462-470.
Mitchell MF, Cantor SB, Brookner C, Utzinger U, Schottenfeld D, Richards-Kortum R. Screening for squamous intraepithelial lesions with fluorescence spectroscopy. Obstetetrics and Gynecology 1999; 94(5 Pt 2):889-896.
Utzinger U, Trujillo EV, Atkinson EN, Mitchell MF, Cantor SB, Richards-Kortum R. Performance estimation of diagnostic tests for cervical precancer based on fluorescence spectroscopy: effects of tissue type, sample size, population and signal-to-noise ratio. IEEE Transactions on Bio-medical Engineering 1999; 46(11):1293-1303.
Updated April 21, 2008 |